Catalyst Wire Dossier Catalyst Wire Dossier

Rs-PSMA

recombinant soluble prostate-specific membrane antigen
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Rs-PSMA, covering 2012-01-09 to 2012-01-09. Get the full timeline:

Most recent: Clinical Trial Update: Vaccine Therapy of Prostate Cancer Patients With Recombinant Soluble Prostate-Specific Membrane Antigen (Rs-PSMA) Plus the Immunological Adjuvant Alhydrogel [Phase 1]

See pricing